Table 3.
Groups | Test of differences | ||||
---|---|---|---|---|---|
NAC | Placebo | ||||
n/total | % | n/total | % | Chi-squarea | |
Week 4 | 0.28 | ||||
Response | 4/15 | 26.7 | 5/14 | 35.7 | |
No response | 11/15 | 73.3 | 9/14 | 64.3 | |
Week 8 | 0.07 | ||||
Response | 5/13 | 38.5 | 4/12 | 33.3 | |
No response | 8/13 | 61.5 | 8/12 | 66.7 | |
Week 12 | 0.15 | ||||
Response | 6/12 | 50.0 | 5/11 | 45.5 | |
No response | 6/12 | 50.0 | 6/11 | 54.5 |
aOne-tailed significance + p < .10; *p < .05. No p values for these chi-squares reached significance at .05 and ranged from .60 to .79
Response = very much improved (1) or much improved (2); no response = minimally improved (3), no change (4), minimally worse (5); no participants scored much worse (6) or very much worse (7)
NAC N-acetylcysteine